BACKGROUND AND PURPOSE:Characterization of radiotherapy activity and its trend over time. Gathering of parameters for future planning of our resources, applicable to similar population areas. Performing a clinical audit of appropriate use of radiotherapy. MATERIAL AND METHODS:Analysis of 9782 patients treated between 1998 and 2008. Descriptive statistics of pathologies and social/demographic characteristics. Intention of treatment. The rate of radiotherapy utilization was estimated and compared with those considered optimal. Rate of reirradiation. RESULTS:The average global rate of radiotherapy utilization for the period was 32.7%. It increased by 23% between 1998 and 2008, while the population of the area rose by 1.04%, equaling an average 1.13 irradiations/1000 inhabitants/year. Radiation treatment has increased by 13.6, 2.3, 1.6 and 1.06 times in patients with prostate, breast, rectal and lung cancer, respectively. Eight percent of radiotherapy treatments involve concurrent chemotherapy. The proportion of treatments with palliative intent was 18.2%. The overall underutilization of radiation therapy in our environment was an estimated 13.4%. CONCLUSIONS:The grade of adequacy of radiation rates in relation with scientific evidence was globally considered suboptimal, especially in lung cancer. There was an upward trend of irradiation in breast and prostate cancer, tending toward rates considered optimal.

译文

背景与目的:放射治疗活性的表征及其随时间的趋势。为将来的资源计划收集参数,适用于类似的人口区域。对放射疗法的适当使用进行临床审核。
材料与方法:分析1998年至2008年间治疗的9782例患者。病理和社会/人口统计学特征的描述性统计数据。用心治疗。估计放射疗法的利用率,并将其与最佳放射疗法的利用率进行比较。再照射率。
结果:该期间全球平均放射治疗利用率为32.7%。在1998年至2008年期间,它增长了23%,而该地区的人口增长了1.04%,相当于每1000名居民/年平均1.13辐射。前列腺癌,乳腺癌,直肠癌和肺癌患者的放射治疗分别增加了13.6倍,2.3倍,1.6倍和1.06倍。百分之八的放疗涉及同步化疗。姑息治疗的比例为18.2%。在我们的环境中,放射治疗的总体利用不足估计为13.4%。
结论:放射率与科学证据有关的充分程度在全球范围内被认为是次优的,尤其是在肺癌中。乳腺癌和前列腺癌的放射线呈上升趋势,趋向于认为最佳的放射率。

+1
+2
100研值 100研值 ¥99课程
检索文献一次
下载文献一次

去下载>

成功解锁2个技能,为你点赞

《SCI写作十大必备语法》
解决你的SCI语法难题!

技能熟练度+1

视频课《玩转文献检索》
让你成为检索达人!

恭喜完成新手挑战

手机微信扫一扫,添加好友领取

免费领《Endnote文献管理工具+教程》

微信扫码, 免费领取

手机登录

获取验证码
登录